The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice

Journal of Alzheimer's Disease

Volumn 18, Issue 3, 2009, Pages 565-579

  Linkous, David H ^a,b   Adlard, Paul A ^c,d   Wanschura, Patricia B ^a   Conko, Kathryn M ^e   Flinn, Jane M ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e U S GEOLOGICAL SURVEY   (United States)

Author keywords

Alzheimer's disease; Amyloid plaques; Metals; Morris water maze; Nutrition; Spatial memory; Tg2576; Transgenic mice; Westaway; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; ZINC;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHAM FEEDING; SPATIAL MEMORY; TRANSGENIC MOUSE; WEANING; WILD TYPE;

EID: 72949112330     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1162     Document Type: Article

References (75)

1. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5, 421-432.
2. Adlard PA, Bush AI (2006) Metals and Alzheimer's disease. J Alzheimers Dis 10, 145-163.
3. Flinn JM, Kesslak JP, Head E, Cano K, Lanzirotti A, Rao W, Jones BF, Bertsch P, Frederickson CJ, Linkous DH (2007) Alzheimer disease Aβ plaque formations have significantly more K, Fe, Cu, and Zn than surrounding tissue, detected with microprobe synchrotron X-ray fluorescence. Soc Neurosci Abstr, Program No. 889.7.
4. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, zinc and iron in Alzheimer's disease senile plaques. J Neurol Sci 158, 88-95.
5. SuhSW, Jensen KB, Jensen MJ, Silva DS,Kesslak PJ, Danscher G, Frederickson CJ (2000) Histochemically-reactive zinc in amyloid plaques, angiopathy and degenerating neurons of Alzheimer diseased brains. Brain Res 852, 274-278.
6. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V, Winblad B, Naslund J, Bush AI (2006) Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75.
7. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T,KokG, RitchieCW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxyquinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43-55.
8. Cuajungco MP, Faget KY (2003) Zinc takes the center stage: its paradoxical role in Alzheimer disease. Brain Res Rev 41, 44-56.
9. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag Y, Perry G, Bush AI (2000) Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275, 19439-19442.
10. House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C (2004) Aluminum, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 6, 291-301.
11. Lee J-L, Cole TB, Palmiter RD, Suh SW, Koh J-Y (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99, 7705-7710.
12. Age-Related Eye Disease Study (AREDS) Research Group (2002) The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS report number 7. J Nutr 132, 697-702.
13. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci USA 100, 11065-11069.
14. Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunden KR (1999) Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20, 581-589.
15. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2, 271-276.
16. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, MA Kuskowski, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84.
17. ong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J Comp Neurol 500, 311-321.
18. Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW (2007) Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28, 213-225.
19. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, SalterMW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloidbeta. Nat Neurosci 8, 1051-1058.
20. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
21. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St. George-Hyslop P, Westaway D (2000) A-beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982.
22. Linkous DH, Smith LN, Conko KM, Jones BF, Flinn JM (2004) Differential effects of zinc association in drinking waters on spatial memory. Metal Ions Biol Med 8, 390-395.
23. Chrosniak LD, Smith LN, Flinn JM, McDonald C, Jones BF (2006) Effects of enhanced zinc and copper in drinking water on spatial memory and fear conditioning. J Geochem Explor 88, 91-94.
24. Thompson JH, Diefendorf A, Linkous DH, Chrosniak L, Conko KM, Jones BF, Smith LN, Flinn JM, McDonald CG (2004) Enhancement of zinc in drinking water (10 ppm ZnCO3) impairs cognitive ability in wild-type APP2576 mice. Soc Neurosci Abstr, 444.3.
25. Morris RG (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60.
26. Lipp HP, Wolfer DP (1998) Genetically modified mice and cognition. Current Opinn Neurobiol 8, 272-280.
27. Spooner RI, Thomson A, Hall J, Morris RG, Salter SH (1994) The Atlantis platform: a new design and further developments of Buresova's on-demand platform for the water maze. Learn Mem 1, 3-11.
28. Shukkit-Hale B, Mouzakis G, Joseph JA (1998) Psychomotor and spatial memory performance in aging male Fischer 344 rats. Exp Gerontology 33, 615-624.
29. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd Ed, Academic Press, San Diego.
30. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25, 4217-4221.
31. Flinn JM, Hunter D, Linkous DH, Lanzirotti A, Smith L, Brightwell J, Jones BF (2005) Enhanced zinc consumption causes memory deficits and increased brain levels of zinc. Physiol Behav 83, 793-803.
32. Turner TY, Soliman MR (2000) Effects of zinc on spatial reference memory and brain dopamine (D1) receptor binding kinetics in rats. Prog Neuropsychopharmacol Biol Psychiatry 24, 1203-1217.
33. Micheli T, Burns A, Fitzgerald A, Flinn JM (2007) Cognitive deficits associated with enhanced zinc consumption, and the role of copper. Association for Psychological Science Annual Meeting, VIII-044.
34. Frederickson CJ, Giblin LJ, Balaji RV, Masalha R, Frederickson CJ, Zeng Y, Lopez EV, Koh JY, Chorin U, Besser L, Hershfinkel M, Li Y, Thompson RB, Krezel A (2006) Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration. J Neurosci Methods 154, 19-29.
35. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW(1996) The role of zinc in selective neuronal death after transient global ischemia. Science 272, 1013-1016.
36. Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6, 449-462.
37. Ho Y, Samarasinghe R, Knoch ME, Lewis M, Aizenman E, DeFrancoDB(2008) Selective inhibition ofMitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. Mol Pharmacol 74, 1141-1151.
38. Sensi SL,Yin HZ, Carriedo SG, Rao SS,Weiss JH (1999) Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA 95, 2414-2419.
39. Peters S, Koh J, Choi D (1987) Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science 236, 589-593.
40. Westbrook GL, Mayer ML (1987) Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328, 640-643.
41. Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, Rungby J, Lund S, Doering P, Danscher G (2007) Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 150, 357-369.
42. Linkous DH, Koh JY, Flinn JM, Lanzirotti A, Bertsch P, Jones BF, Fredrickson CJ (2008) Evidence that the ZnT-3 protein controls the total amount of elemental zinc in synaptic vesicles. J Histochem Cytochem 56, 3-6.
43. LaSalle JM, Bataille T, Halley H (2000) Reversible inactivation of the Hippocampal mossy fiber synapses in mice impairs spatial learning, but neither consolidation nor memory retrieval, in the Morris navigation task. Neurobiol Learn Mem 73, 243-257.
44. Lopantsev V, Wenzel HJ, Cole TB, Palmiter RD, Schwartzkroin PA (2003) Lack of vesicular zinc in mossy fibers does not affect synaptic excitability of CA3 pyramidal cells in zinc transporter 3 knockout mice. Neurosci 116, 237-248.
45. Sandstead HH (1995) Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 61(3S), 621S-624S.
46. Sinha S, Taly AB (2008) Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap. J Neurol Sci 264, 129-132.
47. Porea TJ, Belmont JW, Mahoney DH (2000) Zinc-induced anemia and neutropenia in an adolescent. J Pediatr 136, 688-690.
48. Salzman MB, Smith EM, Koo C (2002) Excessive oral zinc supplementation. J Pediatr Hematol Oncol 24, 582-584.
49. Storey ML, Greiger JL (1987) Iron, zinc and copper interaction: chronic versus acute responses in rats. J Nutrition 117, 1434-1442.
50. Railey AM, Smith LN, Moran K, Veejay M, Fitzgerald A, Micheli T, Flinn JM, Jones BF, Chrosniak LD (2006) Cognitive effects of long term enhanced dietary zinc consumption, modulation by copper. Soc Neurosci Abstr, 265.10.
51. Schlief ML, Craig AM, Gitlin JD (2005) NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J Neurosci 25, 239-246.
52. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37, 925-937.
53. Bush AI (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J Alzheimers Dis 15, 223-240.
54. Carson JA, Turner AJ (2002) Beta-amyloid catabolism: roles for neprilysin (NEP) and other metalopeptidases? J Neurochem 81, 1-8.
55. Molńar Z, Kov́acs P, Laczḱo I, Sóos K, Fülöp L, Penke B, Lengyel I (2004) Enhanced G-protein activation by a mixture a Abeta(25-35), Abeta(1-40/42) and zinc. J Neurochem 89, 1215-1223.
56. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX (2005) Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 86, 147-159.
57. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, Multhaup G (1999) Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. J Biochem 344, 461-467.
58. BayerTA, Schäfer S, Simons A,Kemmling A, KamerT,Tepest R, Eckert A, Schüssel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup, G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100, 14187-14192.
59. Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI (2000) Alzheimer's disease, beta amyloid and zinc. J Nutr 130(5S), 1488S-1492S.
60. Khan A, Dobson JP, Exley C (2006) Redox cycling of iron by Abeta42. Free Radic Biol Med 40, 557-569.
61. Dong J, Robertson JD, Markesbery WR, Lovell MA (2008) Serum zinc in the progression of Alzheimer's disease. J Alzheimers Dis 15, 443-450.
62. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT (1997) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56, 965-973.
63. Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Matsubara E, Abe K, Nakazato Y (2002) Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neuritis. Virchows Arch 441, 358-367.
64. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
65. Maret W, Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20, 3-18.
66. Hamadami JD, Fuchs GJ, Osendarp SJ, Huda SN, Grantham-McGregor SM (2002) Zinc supplementation during pregnancy and effects on mental development and behavior of infants: a follow-up study. Lancet 360, 290-294.
67. Penland JG, Milne DB, Davis CW (2000) Moderately high zinc intake impairs verbal memory of healthy postmenopausal women on a low copper diet. In Trace Elements in Man and Animals 10, Eds. Roussel AM, Anderson RA Favier AE: Kluwer Academic Press.
68. Johnson AR, Munoz A, Gottlieb JL, Jarrard DF (2007) High dose zinc increases hospital admissions due to genitourinary complications. J Urol 177, 639-643.
69. Kaiser J (1994) Alzheimer's: could there be a zinc link? Science 265, 1464-1467.
70. Lengyel I, Flinn JM, PetöT, Linkous DH, Cano K, Bird AC, Lanzirotti A, Frederickson CJ, Van Kuijk FJ (2007) High concentration of zinc in sub-retinal deposits. Exp Eye Res 84, 772-780.
71. Ervin RB, Kennedy-Stephenson J (2002) Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr 132, 3422-3427.
72. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham CJ, Volitakis I, Fraser FW, Kim YS, Huang X, Goldstein L, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with copper-zinc chelators markedly and rapidly inhibits betaamyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
73. Dedeoglu A, Cormier K, Payton S, Tseitlin K, Kremsky JN, Lai L, Li X, Moir RD, Tanzi RE, Bush AI, Kowall NW, Rogers JT, Huang X(2004) Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis. Exp Gerontol 39, 1641-1649.
74. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li Q-X, Tammer A, Carrington D,Mavros C,Volitakis I, XilinasM, Ames D, Davis S, Beyreuther K, Tanzi R, Masters C (2003) Metal-Protein attenuation with iodochlorhydroxyquin (Clioquinol) targeting A[beta] amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial. Arch Neurol 60, 1685-1691.
75. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW, PBT2-201-EURO study group (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIA, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7, 779-786.